Ursodeoxycholic Acid Hmoov CAS No.128-13-2
Khoom Source: Synthetic
Khoom Specification: Ntau dua lossis sib npaug li 99%
CAS Nr .: 128-13-2
Molecular Formula: C₂₄H₄₀O₄
Molecular Luj: 392.57 g / mol
Txoj Kev Xeem: HPLC
Cov khoom xyaw nquag: Ursodeoxycholic Acid
Cov yam ntxwv ntawm cov khoom: Dawb los yog tawm -dawb crystalline hmoov.
Ntim Cov Khoom: 1kg / hnab; 25kg / nruas, customizable
Cia Lub Sijhawm: Khaws kaw, tiv thaiv lub teeb, nyob rau hauv qhov chaw txias, qhuav (pom zoo cia kub 2-8 degree).
Lub neej txee: 24 lub hlis
Khoom Description
Peb lub siab -purity ursodeoxycholic acid API (CAS 128-13-}2), uas yog tsim los siv cov cuab yeej ua ke siab heev, yog tsim tshwj xeeb los ua kom tau raws li cov kev lag luam kev lag luam nruj thoob ntiaj teb xav tau rau cov kua tsib acid tseem ceeb APIs. Cov khoom lag luam ua tiav ntau dua lossis sib npaug li 98% HPLC ntau qhov purity (nrog Ntau dua lossis sib npaug rau 99% siab- cov khoom tshwj xeeb muaj), ua raws li cov qauv tshuaj loj xws li CP/USP/EP. Nws xyuas kom meej molecular structural sib xws (C₂₄H₄₀O₄) thiab cov impurity tsawg (tus neeg tsis paub impurities Tsawg dua lossis sib npaug li 0.1%). Manufacturing adheres rau cov kws tshuaj GMP tswj systems, kom ntseeg tau tag nrho traceability los ntawm raw cov ntaub ntawv mus rau tiav cov khoom xeem thiab zoo ib yam batch-rau-batch stability.
Cov khoom muaj nuj nqi
Cholesterol Dissolution: Txo cov roj cholesterol saturation hauv cov kua tsib, txhawb kev tawg ntawm cov cholesterol gallstones.
Kev Tiv Thaiv Hepatocyte: Hloov cov kua tsib kua qaub (piv txwv li, lithocholic acid), txo qis hepatocyte membrane puas.
Txhim kho Biliary Stasis: Ua kom cov kua tsib tso tawm, txo cov mob cholestatic daim siab.
Immune Modulation: Tshem tawm qhov txawv txav MHC qhia hauv hepatocytes, txo cov lus teb autoimmune.
Cov khoom Apdaim ntawv thov
Primary Biliary Cholangitis (PBC) → Ua ntej - kab mob tus neeg sawv cev (slows kab mob, txhim kho biochemical markers).
Cholesterol Gallstones → Qhia rau kev ua haujlwm ntawm lub gallbladder pob zeb hauv cov neeg mob uas tsis tuaj yeem ua haujlwm (lithotripsy therapy).
Pharmacological teebmeem
Raws li cov txheej txheem no, UDCA tsim cov tshuaj muaj txiaj ntsig zoo hauv qab no hauv vivo:
• Cholagogue thiab Hepatoprotective:UDCA exerts ib txwm cholagogue thiab hepatoprotective teebmeem los ntawm kev txhawb cov kua tsib kua qaub excretion thiab tshem tawm cov kua tsib kua qaub.
• Anti-inflammatory thiab Antioxidant:UDCA qhia txog kev tiv thaiv- mob thiab tiv thaiv kev ua haujlwm hauv tib neeg lub plab zom mov epithelial hlwb.
• Txhim kho gallbladder Function:Hauv cov neeg mob gallstones, UDCA supplementation ho txhim khu lub gallbladder smooth nqaij contractility.
Cim npe nrov: ursodeoxycholic acid hmoov cas no.128-13-2, Tuam Tshoj ursodeoxycholic acid hmoov cas no.128-13-2 manufacturers, lwm tus, Hoobkas
You Might Also Like
Xa kev nug